KITABIS PAK vs NEOMYCIN SULFATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. KITABIS PAK and NEOMYCIN SULFATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KITABIS PAK	NEOMYCIN SULFATE
Rating	New	48/100
Pharmacy pays	$1.07 /mL	~$25.36 /30
Type	RX	RX
Active ingredient	TOBRAMYCIN	NEOMYCIN SULFATE
Manufacturer	Pulmoflow Inc	Teva
Dosage forms	Solution	Topical, Tablet
Drug class	Aminoglycoside Antibacterial	Aminoglycoside Antibacterial
Boxed warning	None	Boxed warning
Treats	Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections	Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases

kitabis pak neomycin sulfate

Rating

New

48/100

Pharmacy pays

$1.07 /mL

~$25.36 /30

Type

Active ingredient

TOBRAMYCIN

NEOMYCIN SULFATE

Manufacturer

Pulmoflow Inc

Teva

Dosage forms

Solution

Topical, Tablet

Drug class

Aminoglycoside Antibacterial

Boxed warning

None

Boxed warning

Treats

Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections

Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases

Frequently asked questions

What is the difference between Kitabis Pak and Neomycin Sulfate?

Kitabis Pak contains Tobramycin, while Neomycin Sulfate contains Neomycin Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.